Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement

被引:5
作者
Mehling, Matthias [1 ]
Drechsler, Henning [2 ]
Kuhle, Jens [1 ]
Hardmeier, Martin [1 ]
Doerries, Ruediger [3 ]
Ruegg, Stephan [1 ]
Gass, Achim [1 ]
机构
[1] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland
[2] SW Texas State Univ, Div Infect Dis, Dallas, TX USA
[3] Univ Hosp, Dept Virol, Mannheim, Germany
关键词
antiretroviral therapy CNS; CNS infection; HAART; HIV; HIVCNS; HIV epilepsy;
D O I
10.1080/13550280701793940
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The authors describe a patient with known human immunodeficiency virus (HIV)-1 infection who presented with two generalized seizures and was found to have extensive white matter disease and a left/bilateral temporo-occipital focal slowing on electroencephalography (EEG). There were no magnetic resonance imaging (MRI) or cerebrospinal fluid (CSF) indications for opportunistic infection. Plasma viremia was controlled, whereas viral replication was uncontrolled in CSF. CSF-specific genotype-guided adaptation of the antiretroviral therapy in order to optimize central nervous system (CNS) penetration resulted in clinical improvement and normalization of MRI and EEG. Our case report illustrates the importance of individualized antiretroviral therapy in HIV infected patients with neurological complications.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 22 条
  • [1] Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: Different patterns of phenotypic resistance in CSF and plasma
    Antinori, A
    Perno, CF
    Giancola, ML
    Forbici, F
    Ippolito, G
    Hoetelmans, RM
    Piscitelli, SC
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (12) : 1787 - 1793
  • [2] BARTON TL, 1992, PHARMACOTHERAPY, V12, P413
  • [3] Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir
    Bates, DE
    Herman, RJ
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1190 - 1195
  • [4] Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults
    DiCenzo, R
    Peterson, D
    Cruttenden, M
    Morse, G
    Riggs, G
    Gelbard, H
    Schifitto, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) : 4328 - 4331
  • [5] Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
    Dore, GJ
    Correll, PK
    Li, YM
    Kaldor, JM
    Cooper, DA
    Brew, BJ
    [J]. AIDS, 1999, 13 (10) : 1249 - 1253
  • [6] Dou HY, 2003, J NEUROSCI, V23, P9162
  • [7] SEIZURE ASSOCIATED WITH ZIDOVUDINE
    DSILVA, M
    LEIBOWITZ, D
    FLAHERTY, JP
    [J]. LANCET, 1995, 346 (8972) : 452 - 452
  • [8] Frequency of seizures and epilepsy in neurological HIV-infected patients
    Kellinghaus, C.
    Engbring, C.
    Kovac, S.
    Moeddel, G.
    Boesebecka, F.
    Fischera, M.
    Anneken, K.
    Kloenne, K.
    Reichelt, D.
    Evers, S.
    Husstedt, I. W.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2008, 17 (01): : 27 - 33
  • [9] Langford TD, 2003, BRAIN PATHOL, V13, P195
  • [10] Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
    Lehrman, G
    Hogue, IB
    Palmer, S
    Jennings, C
    Spina, CA
    Wiegand, A
    Landay, AL
    Coombs, RW
    Richman, DD
    Mellors, JW
    Coffin, JM
    Bosch, RJ
    Margolis, DM
    [J]. LANCET, 2005, 366 (9485) : 549 - 555